neostigmine has been researched along with Heart Septal Defects, Ventricular in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Heart Septal Defects, Ventricular: Developmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishihara, K | 1 |
| Sakahashi, H | 1 |
| Noji, S | 1 |
| Nonoyama, M | 1 |
| Maki, S | 1 |
| Kubo, E | 1 |
| Ohta, J | 1 |
| Aoki, M | 1 |
| Shinoka, T | 1 |
| Koh, E | 1 |
1 other study available for neostigmine and Heart Septal Defects, Ventricular
| Article | Year |
|---|---|
[Investigation of myocardial protection during open heart surgery in infants with ventricular septal defect].
Topics: Cardiac Surgical Procedures; Cardioplegic Solutions; Extracorporeal Circulation; Female; Glucose; He | 1988 |